IT1178044B - Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina - Google Patents

Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Info

Publication number
IT1178044B
IT1178044B IT48983/84A IT4898384A IT1178044B IT 1178044 B IT1178044 B IT 1178044B IT 48983/84 A IT48983/84 A IT 48983/84A IT 4898384 A IT4898384 A IT 4898384A IT 1178044 B IT1178044 B IT 1178044B
Authority
IT
Italy
Prior art keywords
uridine
treatment
active agent
pharmaceutical active
diseases based
Prior art date
Application number
IT48983/84A
Other languages
English (en)
Other versions
IT8448983A1 (it
IT8448983A0 (it
Inventor
Mario Materazzi
Luca Giovanna De
Vincenzo Politi
Stazio Giovanni Di
Original Assignee
Polifarma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polifarma Spa filed Critical Polifarma Spa
Priority to IT48983/84A priority Critical patent/IT1178044B/it
Publication of IT8448983A0 publication Critical patent/IT8448983A0/it
Priority to EP85830247A priority patent/EP0178267A3/en
Publication of IT8448983A1 publication Critical patent/IT8448983A1/it
Application granted granted Critical
Publication of IT1178044B publication Critical patent/IT1178044B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT48983/84A 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina IT1178044B (it)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
EP85830247A EP0178267A3 (en) 1984-10-09 1985-10-02 a uridine-based pharmaceutically active agent for the treatment of cerebral pathologies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Publications (3)

Publication Number Publication Date
IT8448983A0 IT8448983A0 (it) 1984-10-09
IT8448983A1 IT8448983A1 (it) 1986-04-09
IT1178044B true IT1178044B (it) 1987-09-03

Family

ID=11269269

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48983/84A IT1178044B (it) 1984-10-09 1984-10-09 Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina

Country Status (2)

Country Link
EP (1) EP0178267A3 (it)
IT (1) IT1178044B (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2894610B2 (ja) * 1987-10-28 1999-05-24 プロ−ニューロン，インコーポレーテッド アシル化ウリジンおよびシチジンならびにその使用
US5268365A (en) * 1988-03-11 1993-12-07 Rudolph Frederick B Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance
IT1219667B (it) * 1988-06-21 1990-05-24 Polifarma Spa Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico
US20030026782A1 (en) 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
IT1290781B1 (it) * 1996-05-28 1998-12-10 Polifarma Spa Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
US5962459A (en) * 1996-05-28 1999-10-05 Polifarma S.P.A. Therapeutic active agent for treatment of neuron degenerative diseases
ATE446097T1 (de) * 1998-07-31 2009-11-15 Massachusetts Inst Technology Verwendung von uridin in kombination mit cholin zur behandlung von gedächtnisstörungen
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US8314064B2 (en) * 1998-07-31 2012-11-20 Massachusetts Institute Of Technology Uridine administration stimulates membrane production
US8518882B2 (en) * 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US8143234B2 (en) * 1998-07-31 2012-03-27 Massachusetts Institute Of Technology Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function
BRPI0817387A2 (pt) 2007-11-02 2015-09-08 Massachusetts Inst Technology métodos de conformidade de suplementação dietária de uridina e uso dos mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4260M (it) * 1964-11-18 1966-07-04

Also Published As

Publication number Publication date
EP0178267A3 (en) 1988-09-21
IT8448983A1 (it) 1986-04-09
IT8448983A0 (it) 1984-10-09
EP0178267A2 (en) 1986-04-16

Similar Documents

Publication Publication Date Title
IT8622683A0 (it) Dispositivo terapeutico per la somministrazione di medicamenti.
IT8267184A0 (it) Bendaggio per la somministrazione di medicamenti
IT1128094B (it) Catetere per la somministrazione en dovenosa intermittente di medicamenti
NO864126D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater.
NO851949L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotetralinderivater.
NO864879L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser.
NO864674D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser.
IT1178044B (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
NO862373D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner.
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO862372D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO884176D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater.
IT8721115A0 (it) Fitopreparato per la cura di affezioni cutanee.
IT8521322A0 (it) Composti e composizioni farmaceutiche per la terapia di retinopatie e neuropatie diabetiche.
NO168040C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3'-demetoksyepipodofyllotoksin-glukosidderivater.
NO864101D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO164973C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
FR2604707B1 (fr) Procede de preparation d'un compose therapeutique actif
IT1224741B (it) Dispositivo per il trattamento delle malattie delle gengive
DK576687D0 (da) Terapeutisk aktive alkensyrederivater
NO168473C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylthiazoloner.
NO882282D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazin-amider.
NO883959D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere.
IT1209508B (it) Nuovi medicinali per il trattamento di malattie cardiache.